iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference
PR Newswire —
Participation underscores growing excitement around company's momentum and potential in precision oncology GENEVA, AMSTERDAM and CAMBRIDGE, Mass., Jan. 9, 2026 /PRNewswire/ -- iOnctura, a clinical-stage biopharmaceutical company developing precision oral small molecules for neglected and...